Mocap Systems Spółka z Ograniczoną Odpowiedzialnością (KRS 0000712649, NIP 6152054134) is a Polish company, headquartered in Trójca, Dolnośląskie voivodeship. MOCAP SYSTEMS operates in: Other research and experimental development on natural sciences and engineering (PKD 72.19.Z). Industry: Research and development. The company has been listed in the National Court Register since January 11, 2018.
Historical suspension of activities
Suspension: July 1, 2022 - resumed: June 2, 2025
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Mocap Systems
Identity
- Name
- Mocap Systems Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- January 11, 2018
- Registry status as of
- November 21, 2025
- Latest entry
- June 2, 2025
- Founding act
- 29.09.2017R., NOTARIUSZ ROMAN GRUSKOŚ, KANCELARIA NOTARIALNA W KRAKOWIE AL. GROTTGERA 1/1, REPERTORIUM A NUMER 3946/2017…
Articles of association history (2)
- September 29, 2017: 29.09.2017R., NOTARIUSZ ROMAN GRUSKOŚ, KANCELARIA NOTARIALNA W KRAKOWIE AL. GROTTGERA 1/1, REPERTORIUM A NUMER 3946/2017.
- December 17, 2019: 17.12.2019R. REP. A NR 14531/2019 NOTARIUSZ KAROLINA WARCZAK-MAŃDZIAK, KANCELARIA NOTARIALNA WE WROCŁAWIU - ZMIENIONO §9 UST. 1 ORAZ W §11 DODANO PKT 1A DO UMOWY
Activities
Main activity
72.19.ZOther research and experimental development on natural sciences and engineering
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- 41, 59-900, TRÓJCA, POLSKA
- Voivodeship
- DOLNOŚLĄSKIE
- District
- ZGORZELECKI
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 51.1601, 15.1063approx.
Operational status - Mocap Systems
Founded
January 11, 2018
8 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
TRÓJCA
DOLNOŚLĄSKIE
Primary PKD
72.19.Z
Other research and experimental development on natural sciences and…
Share capital
50.0 K PLN
1,002 shares total
Shareholders
3
shareholders
Board
1 person
Sup. board: 1
Filed years
N/A
Registry entries
23
latest: June 2, 2025
No KPI data - financial statements and valuation are unavailable for this company.
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Mocap Systems.
No ratings
Related articles
News
Bioceltix in the final EMA dialogue phase: BCX-CM-J could become Europe's first veterinary cell-therapy drug for dogs
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase regarding BCX-CM-J - Europe's first veterinary cell-therapy drug from mesenchymal stem cells for dogs with osteoarthritis. Responses to the final EMA questions are due in May 2026; the CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. Pre-commercial biotech: 2024 closed with a PLN 14.9 m loss on zero revenue; cash of PLN 33.6 m at year-end. Trigon DM maintained a buy rating with a price target of PLN 127.2.
News
Captor Therapeutics: PLN 36 m of cash at 30 September 2025, runway to mid-2026 - clinical data versus the cash clock
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) - a pre-commercial biotech specialising in TPD (Targeted Protein Degradation) - closed Q3 2025 with PLN 36 m of cash and grants securing financing to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I - the first patient dosed at Barcelona Clinic Liver Cancer. CT-03 (MCL-1 degrader) nearing clinical entry. Without a new R&D partnership or equity issuance in 2026, the company will need additional financing.
